Close

Genentech (RHHBY) Receives FDA Breakthrough Therapy Designation for Actemra as Giant Cell Arteritis Treatment

Go back to Genentech (RHHBY) Receives FDA Breakthrough Therapy Designation for Actemra as Giant Cell Arteritis Treatment